Loading university
Carl H. June — Dr. Carl H. June's lab at the University of Pennsylvania focuses on developing advanced immunotherapies for blood cancers, particularly through the use of chimeric antigen receptor (CAR) T cell therapies. Their innovative research aims to extend these therapies beyond current limits by combining CAR T cells with genetic editing techniques. The lab works on a range of hematologic malignancies, including multiple myeloma and acute myeloid leukemia, aiming to transform the treatment landscape for these challenging diseases.
Benjamin Franklin Voight — Dr. Benjamin Franklin Voight's lab focuses on understanding how different types of cells in the pancreas work together to regulate blood sugar levels and how their dysfunction can lead to diabetes. They are using advanced techniques to create a detailed map of gene regulation in pancreatic islet cells, with the goal of identifying genetic factors that contribute to diabetes. This work aims to improve patient care and enhance our understanding of diabetes progression.
Christos Davatzikos — Dr. Christos Davatzikos leads a lab at the University of Pennsylvania that focuses on using advanced imaging and machine learning techniques to study the brain. The research primarily explores how the brain changes with aging and how these changes relate to conditions like Alzheimer's disease and glioblastoma. The lab aims to improve early diagnosis and treatment strategies for neurodegenerative disorders using large datasets and innovative analytical methods.
M. Celeste Simon — Dr. M. Celeste Simon's lab focuses on understanding clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer characterized by significant metabolic changes. The lab studies how these metabolic alterations impact tumor behavior and explores new therapeutic strategies to improve treatment outcomes for patients with not only ccRCC but also other related cancers. By utilizing advanced models, they aim to uncover universal metabolic pathways that could be targeted for personalized cancer therapy.
Paul A Janmey — Dr. Paul A. Janmey's lab at the University of Pennsylvania examines how the physical properties of cells and tissues influence their function and contribute to various diseases. The research focuses on the mechanical aspects of biopolymer networks, such as those found in the cytoskeleton and extracellular matrix, and their role in cell behavior. The lab also investigates the dynamics of the cell nucleus and how it responds to mechanical stress, which could provide insights into conditions like cancer and fibrotic diseases.
Shelley L Berger — Dr. Shelley L. Berger's lab at the University of Pennsylvania focuses on understanding the link between epigenetics and metabolism in cancer. The lab studies how changes in these pathways can affect gene expression and contribute to cancer development. They aim to develop new therapeutic strategies by investigating the role of specific enzymes and regulatory elements in these processes.
James C Gee — Dr. James C. Gee's lab at the University of Pennsylvania focuses on enhancing imaging technologies in biomedical research. Their main project, the Advanced Normalization Tools (ANTs), is an open-source software library that offers powerful tools for image processing and analysis, benefiting researchers across various fields. The lab aims to modernize and expand this toolkit to support complex imaging needs and meet the growing demands of the scientific community.
Hao Wu — Dr. Hao Wu's lab at the University of Pennsylvania focuses on how genetic variations impact gene regulatory networks and influence cellular behavior. By using advanced techniques like single-cell multi-omics and machine learning, the lab aims to uncover the complex relationships between genomic variants and gene expression across different cell types. This research is particularly important for understanding human diseases and developmental processes, ultimately paving the way for new therapeutic approaches.
Klaus H Kaestner — Dr. Klaus H. Kaestner's lab focuses on understanding critical cellular and molecular mechanisms in gastrointestinal and pancreatic health. They study unique cells like FOXL1-positive telocytes that are crucial for intestinal development, and examine the role of senescent cells in liver disease and diabetes. Overall, the lab aims to uncover pathways that might lead to better treatments for diseases such as diabetes and gastrointestinal disorders.